 "Online pharmacy Netmed plans to reach all small towns")
Netmed.com, an online pharmacy, plans to start supplying to offline pharmacies apart from selling directly to patients.
Pradeep Dadha, founder and CEO of Netmed, said the company had the requisite infrastructure in place and was awaiting the goods and services tax to begin business-to-business arrangements with pharmacies.
Dadha explained transporting medicines from one state to another would become less taxing in the GST regime. Netmed plans to procure from drug manufacturers and sell to pharmacies it has tie-ups with. At present, the company procures from wholesale and retail shops to cater to its clientele.
Also Read
Netmed wants to spread its network to all Tier-II and Tier-III cities, where Dhadha feels the real market lies. “Why will anyone with a pharmacy in the neighbourhood buy medicines for chronic diseases from an online pharmacy?” he said, adding “In smaller towns and places like the north-east, where there are no other means of buying medicines, online pharmacies are needed.”
Hitesh Sharma, partner and leader of life sciences at Ernst & Young, is of the opinion that while this business will succeed, how long it will take to become successful is not known. He also feels that once online pharmacies become successful, offline pharmacies will also want to convert to the digital platform.
Dadha also plans to have his company listed on the stock exchange in the next four years.
Netmeds Marketplace was launched by Dadha, whose family ran Tamilnadu Dadha Pharmaceuticals, which was acquired by Sun Pharmaceuticals in 1997. S Mohanchand Dadha, father of Pradeep Dadha who founded Tamilnadu Dadha Pharmaceuticals, is now a member of the board of Sun Pharmaceuticals, India’s top drugmaker.
In October 2015, Netmeds received funding worth $50 million (Rs 325 crore) from the healthcare-focused global equity firm OrbiMed, with participation from existing investors MAPE (M&A Private Equity Advisory Group) and the Dadha family investment fund.
In May 2015, MAPE had said it would invest about $10 million in the yet-to-be launched Netmeds, taking the total Series A funding to $60 million.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%